Generic semaglutide There are currently no generic versions of Ozempic, Wegovy, or Rybelsus
Nausea Vomiting Diarrhea In addition to gastrointestinal issues, Semaglutide may also contribute to muscle loss, particularly during rapid weight loss

Key Takeaways on Wegovy Insurance Coverage FDA-approved for weight management : Wegovy (semaglutide 2.4mg) is approved for chronic weight management in adults with BMI 30, or BMI 27 with at least one weight-related comorbidity Commercial insurance coverage is expanding : About 40-50% of employer-sponsored plans now cover GLP-1 medications for weight loss, up from under 20% in 2023 Medicare does NOT cover Wegovy for weight loss : Federal law prohibits Medicare Part D from covering drugs prescribed solely for weight management no exceptions List price without insurance : Approximately $1,349/month ($16,188/year) at retail pharmacy Savings programs available : Novo Nordisk offers a savings card reducing cost to as low as $0-$25/month for eligible commercially insured patients Wegovy is a once-weekly injectable prescription medication containing semaglutide at the 2.4mg dose, manufactured by Novo Nordisk

PattiAMGiglioRVAllottaABrunoADi BellaTStoianAPet alEffect of semaglutide on subclinical atherosclerosis and cardiometabolic compensation: a real-world study in patients with type 2 diabetes
See Online Resource p
Ozempic and Wegovy are delivered as weekly injections